Logo image of STVN

STEVANATO GROUP SPA (STVN) Stock Fundamental Analysis

NYSE:STVN - New York Stock Exchange, Inc. - IT0005452658 - Common Stock - Currency: USD

20.74  -0.12 (-0.58%)

After market: 20.74 0 (0%)

Fundamental Rating

5

Taking everything into account, STVN scores 5 out of 10 in our fundamental rating. STVN was compared to 56 industry peers in the Life Sciences Tools & Services industry. STVN has an excellent profitability rating, but there are some minor concerns on its financial health. STVN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

STVN had positive earnings in the past year.
In the past year STVN had a positive cash flow from operations.
STVN had positive earnings in each of the past 5 years.
STVN had a positive operating cash flow in each of the past 5 years.
STVN Yearly Net Income VS EBIT VS OCF VS FCFSTVN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M -300M

1.2 Ratios

The Return On Assets of STVN (5.06%) is better than 80.36% of its industry peers.
STVN has a better Return On Equity (8.39%) than 82.14% of its industry peers.
The Return On Invested Capital of STVN (7.15%) is better than 78.57% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for STVN is below the industry average of 12.86%.
Industry RankSector Rank
ROA 5.06%
ROE 8.39%
ROIC 7.15%
ROA(3y)6.9%
ROA(5y)7.65%
ROE(3y)11.86%
ROE(5y)15.36%
ROIC(3y)9.71%
ROIC(5y)10.46%
STVN Yearly ROA, ROE, ROICSTVN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

STVN has a Profit Margin of 10.67%. This is amongst the best in the industry. STVN outperforms 82.14% of its industry peers.
STVN's Profit Margin has improved in the last couple of years.
STVN's Operating Margin of 16.38% is amongst the best of the industry. STVN outperforms 82.14% of its industry peers.
In the last couple of years the Operating Margin of STVN has grown nicely.
STVN has a worse Gross Margin (28.73%) than 76.79% of its industry peers.
In the last couple of years the Gross Margin of STVN has grown nicely.
Industry RankSector Rank
OM 16.38%
PM (TTM) 10.67%
GM 28.73%
OM growth 3Y-5.27%
OM growth 5Y7.16%
PM growth 3Y-12.48%
PM growth 5Y7.86%
GM growth 3Y-3.05%
GM growth 5Y2.24%
STVN Yearly Profit, Operating, Gross MarginsSTVN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

4

2. Health

2.1 Basic Checks

STVN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for STVN has been increased compared to 1 year ago.
The number of shares outstanding for STVN has been reduced compared to 5 years ago.
The debt/assets ratio for STVN has been reduced compared to a year ago.
STVN Yearly Shares OutstandingSTVN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
STVN Yearly Total Debt VS Total AssetsSTVN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 5.02 indicates that STVN is not in any danger for bankruptcy at the moment.
STVN's Altman-Z score of 5.02 is amongst the best of the industry. STVN outperforms 85.71% of its industry peers.
A Debt/Equity ratio of 0.26 indicates that STVN is not too dependend on debt financing.
STVN's Debt to Equity ratio of 0.26 is in line compared to the rest of the industry. STVN outperforms 55.36% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z 5.02
ROIC/WACC0.88
WACC8.13%
STVN Yearly LT Debt VS Equity VS FCFSTVN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

A Current Ratio of 1.84 indicates that STVN should not have too much problems paying its short term obligations.
With a Current ratio value of 1.84, STVN is not doing good in the industry: 66.07% of the companies in the same industry are doing better.
STVN has a Quick Ratio of 1.33. This is a normal value and indicates that STVN is financially healthy and should not expect problems in meeting its short term obligations.
STVN has a Quick ratio of 1.33. This is in the lower half of the industry: STVN underperforms 69.64% of its industry peers.
Industry RankSector Rank
Current Ratio 1.84
Quick Ratio 1.33
STVN Yearly Current Assets VS Current LiabilitesSTVN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

6

3. Growth

3.1 Past

STVN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -17.24%.
Measured over the past years, STVN shows a very strong growth in Earnings Per Share. The EPS has been growing by 27.29% on average per year.
STVN shows a small growth in Revenue. In the last year, the Revenue has grown by 1.72%.
Measured over the past years, STVN shows a quite strong growth in Revenue. The Revenue has been growing by 15.53% on average per year.
EPS 1Y (TTM)-17.24%
EPS 3Y-6.42%
EPS 5Y27.29%
EPS Q2Q%5.56%
Revenue 1Y (TTM)1.72%
Revenue growth 3Y9.37%
Revenue growth 5Y15.53%
Sales Q2Q%3.12%

3.2 Future

The Earnings Per Share is expected to grow by 20.19% on average over the next years. This is a very strong growth
STVN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.01% yearly.
EPS Next Y12.62%
EPS Next 2Y17.25%
EPS Next 3Y19.51%
EPS Next 5Y20.19%
Revenue Next Year7.07%
Revenue Next 2Y8.7%
Revenue Next 3Y9.23%
Revenue Next 5Y10.01%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
STVN Yearly Revenue VS EstimatesSTVN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
STVN Yearly EPS VS EstimatesSTVN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.2 0.4 0.6 0.8 1

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

STVN is valuated quite expensively with a Price/Earnings ratio of 37.71.
STVN's Price/Earnings ratio is in line with the industry average.
STVN is valuated rather expensively when we compare the Price/Earnings ratio to 27.85, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 33.73 indicates a quite expensive valuation of STVN.
STVN's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.77, STVN is valued quite expensively.
Industry RankSector Rank
PE 37.71
Fwd PE 33.73
STVN Price Earnings VS Forward Price EarningsSTVN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, STVN is valued a bit cheaper than the industry average as 73.21% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 20.21
STVN Per share dataSTVN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of STVN may justify a higher PE ratio.
STVN's earnings are expected to grow with 19.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.99
PEG (5Y)1.38
EPS Next 2Y17.25%
EPS Next 3Y19.51%

More info and screens

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.26%, STVN is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.51, STVN pays a better dividend. On top of this STVN pays more dividend than 85.71% of the companies listed in the same industry.
With a Dividend Yield of 0.26, STVN pays less dividend than the S&P500 average, which is at 2.45.
Industry RankSector Rank
Dividend Yield 0.26%

5.2 History

STVN has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
STVN Yearly Dividends per shareSTVN Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 0.02 0.04 0.06 0.08

5.3 Sustainability

12.27% of the earnings are spent on dividend by STVN. This is a low number and sustainable payout ratio.
DP12.27%
EPS Next 2Y17.25%
EPS Next 3Y19.51%
STVN Yearly Income VS Free CF VS DividendSTVN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M
STVN Dividend Payout.STVN Dividend Payout, showing the Payout Ratio.STVN Dividend Payout.PayoutRetained Earnings

More info and screens

STEVANATO GROUP SPA

NYSE:STVN (5/1/2025, 9:32:04 PM)

After market: 20.74 0 (0%)

20.74

-0.12 (-0.58%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)03-06 2025-03-06/bmo
Earnings (Next)05-08 2025-05-08/amc
Inst Owners116.81%
Inst Owner Change0.5%
Ins Owners2.04%
Ins Owner ChangeN/A
Market Cap5.66B
Analysts82.5
Price Target27.47 (32.45%)
Short Float %6.39%
Short Ratio9.06
Dividend
Industry RankSector Rank
Dividend Yield 0.26%
Yearly Dividend0.06
Dividend Growth(5Y)N/A
DP12.27%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.28%
Min EPS beat(2)-7.68%
Max EPS beat(2)1.13%
EPS beat(4)1
Avg EPS beat(4)-11.69%
Min EPS beat(4)-29.13%
Max EPS beat(4)1.13%
EPS beat(8)2
Avg EPS beat(8)-7.89%
EPS beat(12)6
Avg EPS beat(12)-3.36%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.04%
Min Revenue beat(2)-0.71%
Max Revenue beat(2)0.62%
Revenue beat(4)1
Avg Revenue beat(4)-0.67%
Min Revenue beat(4)-2.44%
Max Revenue beat(4)0.62%
Revenue beat(8)1
Avg Revenue beat(8)-1.49%
Revenue beat(12)3
Avg Revenue beat(12)-0.86%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.21%
PT rev (3m)0.77%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-7.82%
EPS NY rev (1m)-0.42%
EPS NY rev (3m)-3.11%
Revenue NQ rev (1m)-0.34%
Revenue NQ rev (3m)-1.15%
Revenue NY rev (1m)-0.17%
Revenue NY rev (3m)0.08%
Valuation
Industry RankSector Rank
PE 37.71
Fwd PE 33.73
P/S 4.51
P/FCF N/A
P/OCF 31.95
P/B 3.54
P/tB 3.77
EV/EBITDA 20.21
EPS(TTM)0.55
EY2.65%
EPS(NY)0.61
Fwd EY2.96%
FCF(TTM)-0.66
FCFYN/A
OCF(TTM)0.65
OCFY3.13%
SpS4.6
BVpS5.85
TBVpS5.5
PEG (NY)2.99
PEG (5Y)1.38
Profitability
Industry RankSector Rank
ROA 5.06%
ROE 8.39%
ROCE 9.77%
ROIC 7.15%
ROICexc 7.54%
ROICexgc 7.91%
OM 16.38%
PM (TTM) 10.67%
GM 28.73%
FCFM N/A
ROA(3y)6.9%
ROA(5y)7.65%
ROE(3y)11.86%
ROE(5y)15.36%
ROIC(3y)9.71%
ROIC(5y)10.46%
ROICexc(3y)11.09%
ROICexc(5y)13.59%
ROICexgc(3y)11.88%
ROICexgc(5y)15.21%
ROCE(3y)13.31%
ROCE(5y)14.16%
ROICexcg growth 3Y-28.59%
ROICexcg growth 5Y-6.94%
ROICexc growth 3Y-26.56%
ROICexc growth 5Y-4.42%
OM growth 3Y-5.27%
OM growth 5Y7.16%
PM growth 3Y-12.48%
PM growth 5Y7.86%
GM growth 3Y-3.05%
GM growth 5Y2.24%
F-Score4
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA 1.4
Cap/Depr 388.8%
Cap/Sales 28.4%
Interest Coverage 24.4
Cash Conversion 59.57%
Profit Quality N/A
Current Ratio 1.84
Quick Ratio 1.33
Altman-Z 5.02
F-Score4
WACC8.13%
ROIC/WACC0.88
Cap/Depr(3y)442.35%
Cap/Depr(5y)341.04%
Cap/Sales(3y)31.28%
Cap/Sales(5y)24.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-17.24%
EPS 3Y-6.42%
EPS 5Y27.29%
EPS Q2Q%5.56%
EPS Next Y12.62%
EPS Next 2Y17.25%
EPS Next 3Y19.51%
EPS Next 5Y20.19%
Revenue 1Y (TTM)1.72%
Revenue growth 3Y9.37%
Revenue growth 5Y15.53%
Sales Q2Q%3.12%
Revenue Next Year7.07%
Revenue Next 2Y8.7%
Revenue Next 3Y9.23%
Revenue Next 5Y10.01%
EBIT growth 1Y-16.27%
EBIT growth 3Y3.61%
EBIT growth 5Y23.8%
EBIT Next Year72.91%
EBIT Next 3Y33.15%
EBIT Next 5Y27.72%
FCF growth 1Y53.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y48.06%
OCF growth 3Y5.33%
OCF growth 5Y29.6%